Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Oncotarget|October 15, 2017
Melflufen - a peptidase-potentiated alkylating agent in clinical trialsMalin Wickström, Peter Nygren, Rolf Larsson, et al.
Molecular Cancer Therapeutics|September 19, 2007
The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivoMalin Wickström, John Inge Johnsen, Frida Ponthan, et al.
Cancers|December 10, 2021
<i>PPM1D</i> Is a Therapeutic Target in Childhood Neural TumorsJelena Milosevic, Diana Treis, Susanne Fransson, et al.
Nature Communications|November 26, 2015
Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistanceMalin Wickström, Cecilia Dyberg, Jelena Milosevic, et al.
Frontiers in Pharmacology|September 21, 2023
The multiple functions of miR-574-5p in the neuroblastoma tumor microenvironmentEva Proestler, Julia Donzelli, Sheila Nevermann, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2017
Rho-associated kinase is a therapeutic target in neuroblastomaCecilia Dyberg, Susanne Fransson, Teodora Andonova, et al.
Cell Death & Disease|April 19, 2025
Targeted inhibition of WIP1 and histone H3K27 demethylase activity synergistically suppresses neuroblastoma growthDiana Treis, Kristina Ihrmark Lundberg, Nicola Bell, et al.
Pageof 6